The S&P BSE Sensex has risen about 12% from a low in September, with three members - Reliance Industries, ICICI Bank and HDFC Bank - accounting for 61% of all the gains
Improving profitability in durables, tax cuts to drive earnings
Despite the ongoing slowdown, the company has posted strong organic growth in the past couple of quarters
'We hold around €240 billion of liquidity reserves out of a net balance sheet of about a trillion', said Joshi
Industry players say thanks to the strong market standing of General Atlantic
In early 2016, emerging-market currencies began a two-year rally that took MSCI Inc.'s gauge to a record as investors sought higher-yielding assets
The latest communication comes against the backdrop of Karvy Stock Broking Ltd unauthorisedly transferring securities worth Rs 2,300 crore of more than 95,000 clients, into its account
Investors said while Sebi acted swiftly in the case of Karvy, it has done nothing to address their problem
As per the statement, interest rate options are based on the underlying government 10-year bonds -- the 7.26% 2029 bond and the 6.45% 2029 bond
The fund-raising comes at a time when the company plans to penetrate cities and scale up investments and become a key player in the industry
The increase pushed price of petrol to Rs 75 per litre in the national capital and that of diesel to Rs 66.04 per litre
Sectoral indices ended the session mixed on the NSE. At close, Nifty Realty Index closed with a cut of 1.15 per cent, while Nifty Auto index closed 0.73 per cent higher
Sharp rally boosts returns
From bonus shares to a fat dividend, there's a lot to underpin the price, at least initially
All that happened in the markets today
Karvy is alleged to have gone beyond by using its client securities to raise money for its other businesses, including real estate
In the one-year period, gilt funds had outperformed most other debt categories with gains of over 10 per cent
The outlook for the long-term rating of the company has been revised from 'Stable' to 'Negative'.
The Company has received a consideration of Rs 33.50 crore subject to necessary working capital adjustments
In August this year, Abraxis Biosciences LLC had alleged that SPARC's filing of NDA or Taclantis injection is an act of infringement of the Orange Book listed patents for Abraxane.